Shinpoong Pharmaceutical Co Ltd (019175) — Capital Reinvestment Ratio
Shinpoong Pharmaceutical Co Ltd (019175) has a Capital Reinvestment Ratio of 0.20x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩3.42 Billion) in capital expenditures (₩694.80 Million). See how leveraged is Shinpoong Pharmaceutical Co Ltd's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shinpoong Pharmaceutical Co Ltd Capital Reinvestment Ratio (2015–2025)
This chart tracks Shinpoong Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 7 annual periods. Check Shinpoong Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shinpoong Pharmaceutical Co Ltd (2015–2025)
Year-by-year Capital Reinvestment Ratio for Shinpoong Pharmaceutical Co Ltd from 2015 to 2025. For live market cap and broader valuation context, see market value of Shinpoong Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | ₩17.25 Billion | ₩3.99 Billion | ▲ +74.8% |
| 2020 | 0.13x | ₩20.06 Billion | ₩2.65 Billion | ▼ -78.8% |
| 2019 | 0.62x | ₩19.35 Billion | ₩12.07 Billion | ▲ +1015.9% |
| 2018 | 0.06x | ₩32.05 Billion | ₩1.79 Billion | ▼ -81.6% |
| 2017 | 0.30x | ₩10.15 Billion | ₩3.08 Billion | ▲ +283.0% |
| 2016 | 0.08x | ₩18.96 Billion | ₩1.50 Billion | ▼ -58.7% |
| 2015 | 0.19x | ₩9.89 Billion | ₩1.90 Billion | — |